Climb Bio (CLYM) Current Assets (2020 - 2026)
Climb Bio (CLYM) posted Current Assets of $113.4 million for Q1 2026, up 7.14% on a QoQ basis from $105.8 million in Q4 2025, and up 13.09% year-over-year from $100.3 million in Q1 2025.
Climb Bio (CLYM) Current Assets (2020 - 2026) Analysis & Trends
Climb Bio's Current Assets history runs 7 years deep, the most recent figure standing at $113.4 million for Q1 2026.
- Quarterly Current Assets rose 13.09% year-over-year to $113.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.4 million (up 13.09% YoY) and the FY2025 annual result came in at $105.8 million, down 31.65% from the prior year.
- Current Assets was $113.4 million for Q1 2026 at Climb Bio, up from $105.8 million in the prior quarter.
- Across five years, Current Assets topped out at $226.0 million in Q2 2024 and bottomed at $87.4 million in Q2 2025.
- A 5-year average of $128.0 million and a median of $114.2 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets soared 97.82% — and 2025, when it plunged 61.33%.
- Climb Bio's Current Assets stood at $134.4 million in 2022, then retreated by 17.96% to $110.3 million in 2023, then surged by 40.47% to $154.9 million in 2024, then sank by 31.65% to $105.8 million in 2025, then climbed by 7.14% to $113.4 million in 2026.
- Business Quant data shows CLYM's Current Assets at $113.4 million in Q1 2026, $105.8 million in Q4 2025, and $91.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 113.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.40 Mn |
| Dec 31, 2025 | 105.85 Mn |
| Sep 30, 2025 | 90.96 Mn |
| Jun 30, 2025 | 87.38 Mn |
| Mar 31, 2025 | 100.28 Mn |
| Dec 31, 2024 | 154.87 Mn |
| Sep 30, 2024 | 197.61 Mn |
| Jun 30, 2024 | 226.00 Mn |
| Mar 31, 2024 | 109.22 Mn |
| Dec 31, 2023 | 110.26 Mn |
| Sep 30, 2023 | 112.43 Mn |
| Jun 30, 2023 | 114.24 Mn |
| Mar 31, 2023 | 120.17 Mn |
| Dec 31, 2022 | 134.39 Mn |
| Sep 30, 2022 | 133.17 Mn |
| Jun 30, 2022 | 133.08 Mn |
| Mar 31, 2022 | 133.28 Mn |
| Dec 31, 2021 | 148.25 Mn |
| Sep 30, 2021 | 158.63 Mn |
| Jun 30, 2021 | 104.80 Mn |